P308: The scope of incorporating preemptive pharmacogenomics testing for public healthcare

P308: The scope of incorporating preemptive pharmacogenomics testing for public healthcare

Bibliographic Details
Main Authors:	Joy Sheng, Serjio Rubio, Nirmal Shende, Sherry Dadgar
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774424003492

Similar Items

Clinical implementation of preemptive pharmacogenomics in psychiatryResearch in context
by: Maria Skokou, et al.
Published: (2024-03-01)

Are we PREPAREd? Concerning the “PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study”
by: Ana de Carmo Campos, et al.
Published: (2023-10-01)

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota
by: Lusi Zhang, et al.
Published: (2022-09-01)

Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing
by: Charlotte Vermehren, et al.
Published: (2020-07-01)

A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling
by: Josiah D. Allen, et al.
Published: (2022-03-01)

Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing
by: William J. Canestaro, et al.
Published: (2012-10-01)

Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare
by: Giri J, et al.
Published: (2019-10-01)

P864: Employees’ views and healthcare utilization following employer-sponsored pharmacogenomic testing at a large US healthcare system
by: Elizabeth Charnysh, et al.
Published: (2024-01-01)

Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
by: Azza Ramadan, et al.
Published: (2024-01-01)

Network-on-chip non-preemptive test scheduling /
by: Mohd. Syafiq Mispan, 1984-, et al.
Published: (2010)

Network-on-chip non-preemptive test scheduling
by: Mispan, Mohd. Syafiq
Published: (2010)

Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs’ Pharmacogenomic Testing for the Veterans (PHASER) Program
by: Karina Melendez, et al.
Published: (2023-09-01)

Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
by: Joel Van Heukelom, et al.
Published: (2023-11-01)

Exploring public genomics data for population pharmacogenomics.
by: Kleanthi Lakiotaki, et al.
Published: (2017-01-01)

Population Pharmacogenomics for Precision Public Health in Colombia
by: Shashwat Deepali Nagar, et al.
Published: (2019-03-01)

Pharmacogenomics /
by: Kalow, Werner, et al.
Published: (2005)

Knowledge and attitudes on implementing cardiovascular pharmacogenomic testing
by: Callan Russell, et al.
Published: (2024-03-01)

Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
by: Catriona Hippman, et al.
Published: (2019-08-01)

Pharmacogenomic tests in Oncology - finding the right dose
by: Jeziel Basso, et al.
Published: (2021-10-01)

Updating the landscape of direct-to-consumer pharmacogenomic testing
by: Filipski KK, et al.
Published: (2017-08-01)

Adoption of Pharmacogenomic Testing: A Marketing Perspective
by: Margarita-Ioanna Koufaki, et al.
Published: (2021-09-01)

Network-on-chip non-preemptive test scheduling [electronic resource] /
by: Mohd. Syafiq Mispan, 1984-
Published: (2010)

An LP-Based Algorithm for Scheduling Preemptive and/or Non-Preemptive Real-Time Tasks
by: Hideki HASHIMOTO, et al.
Published: (2010-06-01)

349 Translation of novel multidisciplinary health technologies in the Ontario healthcare system: A case study of pharmacogenomic testing
by: Samuel Neumark, et al.
Published: (2023-04-01)

Artificial Intelligence, Healthcare, Clinical Genomics, and Pharmacogenomics Approaches in Precision Medicine
by: Habiba Abdelhalim, et al.
Published: (2022-07-01)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
by: Takahashi PY, et al.
Published: (2021-05-01)

Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support
by: Hoath James I, et al.
Published: (2010-10-01)

Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals
by: Yang Wang, et al.
Published: (2021-11-01)

Are Community Pharmacists Ready to Deliver Pharmacogenomics Testing Services?
by: Heba Ghazal, et al.
Published: (2023-10-01)

Physicians’ Knowledge, Attitude, and Experience of Pharmacogenomic Testing in China
by: Tong Jia, et al.
Published: (2022-12-01)

Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
by: Feng-Hua Loh, et al.
Published: (2021-10-01)

The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies
by: Ann Chen Wu, et al.
Published: (2018-10-01)

Pharmacogenomics of Antibiotics
by: Gabriele Stocco, et al.
Published: (2020-08-01)

PREEMPTIVE CADAVERIC KIDNEY TRANSPLANTATION
by: T. I. Shraer, et al.
Published: (2009-05-01)

Learning to Redress Preemptive Deceit
by: Christopher Williams
Published: (2011-10-01)

Pharmacogenomics of Cardiovascular Pharmacology: Pharmacogenomic Network of Cardiovascular Disease Models
by: Toshio Tanaka, et al.
Published: (2008-01-01)

PHARMACOGENOMICS OF HUMAN P450 OXIDOREDUCTASE
by: Amit V Pandey, et al.
Published: (2014-05-01)

Implementation of a pharmacogenomic program in a Brazilian public institution
by: Suarez-Kurtz, G, et al.
Published: (2020)

IQK 308 - Ergonomik
by: PPTI, Pusat Pengajian Teknologi Industri
Published: (1995)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
by: Stojiljkovic Maja, et al.
Published: (2012-09-01)